loading page

Associations between polymorphisms of TNFSF13B and Primary Sjögren’s Syndrome susceptibility in Primary Sjögren’s Syndrome Patients: a Meta-analysis
  • +5
  • Anhao Zheng,
  • Naiwen Hu,
  • Jing Xu,
  • Ye Yuan,
  • Shumin Zhang,
  • Wenbin Chen,
  • Yanyan Bai,
  • Hongsheng Sun
Anhao Zheng
Shandong University Cheeloo College of Medicine
Author Profile
Naiwen Hu
Shandong Provincial Hospital
Author Profile
Jing Xu
Shandong First Medical University
Author Profile
Ye Yuan
Shandong First Medical University
Author Profile
Shumin Zhang
Shandong First Medical University
Author Profile
Wenbin Chen
Shandong Provincial Hospital
Author Profile
Yanyan Bai
Shandong Provincial Hospital
Author Profile
Hongsheng Sun
Shandong Provincial Hospital

Corresponding Author:13869192509@126.com

Author Profile

Abstract

Objective B cell activating factor (BAFF) is a key regulator of Primary Sjögren’s Syndrome (pSS), which is characterized by B lymphocyte hyperactivity. BAFF is also known as TNF ligand superfamily member 13B (TNFSF13B). This study aimed to explore whether five single nucleotide polymorphisms (SNPs) of the TNFSF13B gene (rs9514827, rs1041569, rs9514828, rs1224141, and rs12583006) are related to pSS susceptibility. Methods We searched Pubmed, Cochrane, Elsevier, Web of Science, CNKI, CQVIP, and WanFang databases (up to January 2023). In a population with pSS, the odds ratios (ORs) with 95% confidence intervals (CIs) of genotypes and each allele were provided to investigate relationships between the polymorphisms of the BAFF (TNFSF13B) gene and pSS. Results The meta-analysis in question contains three studies. In the group of pSS patients and randomly selected health controls (HCs), there was a statistically significant relationship between rs1041569 and rs12583006 and pSS susceptibility, respectively. In fixed models, there were statistical differences in pSS patients and randomly chosen HCs. Conclusions There were relationships of rs1041569 and rs12583006 in the pSS group and HC group. BAFF(TNFSF13B) genes, particularly rs1041569 and rs12583006, were related to pSS susceptibility in pSS patients.
22 Jun 2023Submitted to Immunity, Inflammation and Disease
23 Jun 2023Submission Checks Completed
23 Jun 2023Assigned to Editor
23 Jun 2023Review(s) Completed, Editorial Evaluation Pending
28 Jun 2023Reviewer(s) Assigned
05 Nov 2023Editorial Decision: Revise Minor
10 Nov 20231st Revision Received
13 Nov 2023Submission Checks Completed
13 Nov 2023Assigned to Editor
13 Nov 2023Review(s) Completed, Editorial Evaluation Pending
16 Nov 2023Reviewer(s) Assigned
16 Nov 2023Editorial Decision: Accept
Dec 2023Published in Immunity, Inflammation and Disease volume 11 issue 12. https://doi.org/10.1002/iid3.1103